Because of the recent concern in the United States around the rise of resistant pathogens, intravenous fosfomycin has gained renewed interest because of its activity and demonstrated synergy with other classes of antibiotics.
Amira Bhalodi, PharmD
Advertisement
Articles by Amira Bhalodi, PharmD
Advertisement
Latest Updated Articles
Intravenous Fosfomycin In Development for United StatesOctober 25th 2018
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Grants Priority Review for Dolutegravir in Newborns With HIV
2
10 Infectious Disease Developments That Defined Q2 2026
3
Merck, ADAP Crisis Task Force Agree to Expand IDVYNSO Access in HIV
4
HIV in 2026: Four Experts on Aging, Testing, Equity, and Prevention's Next Era
5